Enhancing the Development and Bringing to Market of
New Dermatological Therapeutic Options
The Dermatology Drug Development Summit series is a unique industry-focused forum dedicated to innovating, accelerating and sharing pharmaceutical best practice on the development and bringing to market of new dermatological drugs, in the treatment of high unmet need.
The dermatology space continues to undergo huge therapeutic innovation and growing competitive pressure, driven by the evolving understanding of the pathophysiology of skin diseases, as well as in the available treatment options for chronic, moderate to severe dermatological conditions and high unmet need that affects the lives of patients worldwide.
Returning in 2020, the Dermatology Drug Development Summit provides leading industry experts with a unique forum to debate the end-to-end challenges in dermatology drug development: from discovering new research on key disease pathways, to unveiling critical preclinical insights, discussing formulation strategies, defining the optimal clinical development plans or evaluating commercialization approaches.
Register your interest to receive agenda and speaker updates as they are announced.
Our 2019 Expert Speakers Included:
Head of New Treatment Strategies, Immune-Dermatology
Senior Director – Translational Research
VP & Head of North America Medical Affairs for Immunology
2019 Partners Included: